57
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID-19 is characterized by excessive production of pro-inflammatory cytokines and acute lung damage associated with patient mortality. While multiple inflammatory cytokines are produced by innate immune cells during SARS-CoV-2 infection, we found that only the combination of TNF-α and IFN-γ induced inflammatory cell death characterized by pyroptosis, apoptosis, and necroptosis (PANoptosis). Mechanistically, TNF-α and IFN-γ co-treatment activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD–mediated PANoptosis. TNF-α and IFN-γ caused a lethal cytokine shock in mice that mirrors the tissue damage and inflammation of COVID-19, and inhibiting PANoptosis protected mice from this pathology and death. Furthermore, treating with neutralizing antibodies against TNF-α and IFN-γ protected mice from mortality during SARS-CoV-2 infection, sepsis, hemophagocytic lymphohistiocytosis, and cytokine shock. Collectively, our findings suggest that blocking the cytokine-mediated inflammatory cell death signaling pathway identified here may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.

          Highlights

          • Of several cytokines tested, only synergism of TNF-α and IFN-γ induces PANoptosis

          • TNF-α and IFN-γ–mediated PANoptosis perpetuates cytokine storm

          • TNF-α and IFN-γ shock mirrors cytokine storm syndromes, including COVID-19

          • Neutralizing TNF-α and IFN-γ protects against SARS-CoV-2, HLH, and sepsis in mice

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          Cell
          Elsevier Inc.
          0092-8674
          1097-4172
          19 November 2020
          19 November 2020
          Affiliations
          [1 ]Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [2 ]Department of Microbiology, Immunology, & Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 38163, USA
          [3 ]The Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [4 ]Hartwell Center for Bioinformatics & Biotechnology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [5 ]Animal Resources Center and Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          [6 ]Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA
          Author notes
          []Lead contact; correspondence to: Thirumala-Devi Kanneganti Department of Immunology, St. Jude Children's Research Hospital, MS #351, 262 Danny Thomas Place , Memphis TN 38105-3678, Tel: (901) 595-3634; Fax. (901) 595-5766.
          [#]

          Equal Contribution

          Article
          S0092-8674(20)31542-7
          10.1016/j.cell.2020.11.025
          7674074
          33278357
          c2be6237-92a5-4bab-b027-ebe10220c2f5
          © 2020 Elsevier Inc.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 21 September 2020
          : 22 October 2020
          : 13 November 2020
          Categories
          Article

          Cell biology
          Cell biology

          Comments

          Comment on this article